Reston Hospital Center
December 22, 2021

Reston, VA – December 22, 2021 Reston Hospital Center today announced that it has successfully completed the first surgery to implant a new treatment for obstructive sleep apnea (OSA). Using an FDA-approved therapy called Inspire®, the new treatment is an option for people who cannot use Continuous Positive Airway Pressure (CPAP) therapy.

The Inspire system is implanted during a short, outpatient procedure and is placed under the skin of the neck and chest through two small incisions. Most patients return home the same day with little recovery time needed. At Reston, the procedure was done by an experienced Otolaryngologist, commonly called an ENT physician.

The sleep apnea treatment works inside the body with a patient’s natural breathing process. Mild stimulation opens the airway, allowing oxygen to flow naturally, without waking. The patient uses a small handheld remote to turn on the device before bed and off when they wake up.

“We are excited to have performed this procedure at Reston Hospital Center,” said Dr. Edwin Lee. “Having a new treatment option for obstructive sleep apnea offers hope to those who were looking at a lifetime of using a CPAP machine.”

Obstructive sleep apnea affects 22 million Americans. When left untreated, OSA can cause vehicle and workplace accidents, worsening mood and memory, stroke, heart attack, and even death. It occurs when the airway collapses during sleep and blocks the flow of oxygen to the brain. The brain senses a lack of oxygen and wakes the body up just long enough to take a breath, then falls back asleep. This cycle repeats throughout the night and causes poor, disruptive sleep.

Reston Hospital Center physicians have been closely following the safety and efficacy of the Inspire system during its five-year clinical trial. The Hospital’s patient-centered care includes investing in resources that matter most to patients: the right tools, the latest technology and the most experienced doctors and staff.

“Innovative and advanced treatments are available at Reston Hospital Center,” said John Deardorff, HCA Healthcare Northern Virginia market’s chief executive officer. “By embracing new and proven technology, like the Inspire system, our providers are better able to meet the needs of their patients and our community.”